Cargando…
The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
The cell-autonomous circadian clock regulates IgE- and IL-33-mediated mast cell activation, both of which are key events in the development of allergic diseases. Accordingly, clock modifiers could be used to treat allergic diseases, as well as many other circadian-related diseases, such as sleep and...
Autores principales: | Ishimaru, Kayoko, Nakajima, Shotaro, Yu, Guannan, Nakamura, Yuki, Nakao, Atsuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941044/ https://www.ncbi.nlm.nih.gov/pubmed/31847374 http://dx.doi.org/10.3390/ijms20246320 |
Ejemplares similares
-
In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
por: Geldof, Lore, et al.
Publicado: (2016) -
REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022) -
SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022) -
Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the
Human Glioblastoma T98G Cells
por: Wagner, Paula M., et al.
Publicado: (2019) -
SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy
por: Shen, Weitao, et al.
Publicado: (2020)